Radiologist and young man discussing x-ray images of joints

FOMAT Medical Research Expands into Rheumatology with Strategic Partnership with Arthritis & Rheumatology Centers

FOMAT Medical Research, California’s leading research site network, has announced a significant expansion in its clinical research capabilities through a strategic partnership with Arthritis & Rheumatology Centers. Led by Dr. Tony Makhlouf, Arthritis & Rheumatology Centers brings specialized expertise to the collaboration, which focuses on advancing clinical research in Rheumatology. With multiple clinics across Ventura County, the group is known for its excellence in treating diseases such as rheumatoid arthritis, lupus, osteoarthritis, gout, and psoriatic arthritis, among others.

This partnership signifies a remarkable advancement for FOMAT Medical Research, as it extends the organization’s reach into Rheumatology—a field that requires specific knowledge and dedicated clinical approaches. By collaborating with Arthritis & Rheumatology Centers, FOMAT Medical Research aims to accelerate the development of new therapies, ultimately benefiting both sponsors and patients in Southern California and beyond.

Expanding Clinical Research Capabilities in Rheumatology

For FOMAT Medical Research, this collaboration aligns perfectly with their mission to innovate in clinical research and provide a robust platform for sponsors looking to advance treatments in specialized areas. Rheumatology encompasses a wide range of diseases that affect the joints, muscles, and connective tissues, making specialized expertise essential for effective treatment and management. This partnership with Arthritis & Rheumatology Centers allows FOMAT to offer new research opportunities in a field that is seeing a growing demand for novel therapies and clinical advancements.

According to Nicholas Focil, CEO of FOMAT Medical Research, the partnership is set to bring considerable benefits to the clinical research landscape. “We are thrilled to join forces with Arthritis & Rheumatology Centers,” Focil stated. “This collaboration demonstrates our commitment to driving innovation in clinical research and providing sponsors with a comprehensive platform to advance their therapies in this critical therapeutic area. Together, we can make substantial progress in improving the lives of patients affected by Rheumatologic diseases while continuing to move the needle on diversity in clinical trials.”

Leveraging Specialized Expertise for Enhanced Research Outcomes

Arthritis & Rheumatology Centers, under the leadership of Dr. Tony Makhlouf, has a longstanding history of providing exceptional care to patients with complex Rheumatologic diseases. Dr. Makhlouf brings invaluable experience and knowledge to the partnership, helping FOMAT Medical Research tap into a niche market that requires a deep understanding of autoimmune diseases, chronic pain management, and inflammatory conditions. Dr. Makhlouf is equally enthusiastic about the collaboration, stating, “Partnering with FOMAT Medical Research provides a tremendous opportunity to combine our Rheumatology expertise with their extensive research site network. By working together, we can accelerate the development of novel therapies and make a significant impact in treating and managing Rheumatologic diseases. This collaboration underscores our shared commitment to advancing patient care and contributing to the field of Rheumatology.”

Through this partnership, FOMAT Medical Research and Arthritis & Rheumatology Centers will be able to conduct more comprehensive clinical trials that cover the full spectrum of Rheumatologic diseases. These trials are crucial for developing new therapies that can significantly improve patients’ quality of life, especially for those with chronic conditions. The collaboration also provides a unique opportunity for sponsors to align their pipeline therapies with a practice that has a deep commitment to patient care and a robust research infrastructure.

A New Horizon for Sponsors and Patients Alike

For industry sponsors, this collaboration offers a streamlined platform to access a wide range of Rheumatologic conditions. By working with FOMAT Medical Research, sponsors can leverage an extensive network that spans multiple locations and provides access to diverse patient populations. This is particularly valuable for sponsors seeking to understand how their therapies perform across different demographics and health profiles. FOMAT’s research network, combined with the expertise of Arthritis & Rheumatology Centers, provides sponsors with the insights needed to accelerate the development of treatments, making it an ideal partnership for those looking to make strides in Rheumatology.

Patients will also experience direct benefits from this expanded research network. With increased access to clinical trials, individuals with Rheumatologic diseases will have opportunities to participate in studies that offer cutting-edge treatments and the potential for better disease management. By expanding its research capabilities, FOMAT Medical Research is helping ensure that patients who suffer from these often-debilitating conditions have access to innovative therapies that might not otherwise be available to them. This partnership exemplifies both organizations’ dedication to improving patient outcomes and advancing the field of Rheumatology.

A Shared Vision for the Future of Rheumatology Research

The collaboration between FOMAT Medical Research and Arthritis & Rheumatology Centers not only strengthens the clinical research landscape but also sets a precedent for how partnerships can bring together different areas of expertise to advance healthcare. By combining a specialized practice group with a leading research network, this partnership demonstrates how innovation and collaboration can work hand-in-hand to accelerate the development of life-changing therapies.

FOMAT Medical Research has always prioritized expanding its capabilities in response to the evolving needs of sponsors and patients. This partnership reaffirms its commitment to being at the forefront of clinical research by continually seeking ways to broaden its impact across various therapeutic areas. As the field of Rheumatology continues to evolve, partnerships like this one will play a vital role in ensuring that new treatments are both effective and accessible to those who need them most.

Interested in learning more about this partnership and the potential it holds for advancing Rheumatology research? Read the full press release here for additional insights and details on how FOMAT Medical Research and Arthritis & Rheumatology Centers are working together to make a difference.

Contact Us

    Comments are closed.